Mestag Therapeutics

Fibroblast Biology for Antibody Discovery

Undisclosed RD inflammatory & autoimmune conditions

Mestag Therapeutics is focused on developing innovative treatments for Cancer and inflammatory diseases. They are passionate about making a difference in patients’ lives, through the targeting of fibroblasts, which play a critical role in the immune system's response to these conditions. Certain fibroblast populations are implicated in drivers of diseases such as inflammatory bowel disease, lupus, and multiple solid tumors. They are developing a pipeline of what they call first-in-class antibody therapies designed to target these specific fibroblast sub-populations and improve the immune system's function. Mestag Therapeutics was recognized on the Fierce 15 list of innovative biotechnology companies in 2021 and collaborates with Janssen Biotech, Inc for target discovery.